Heikki Helin

Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab

Minna Tanner, Maija Hollmén, Teemu T. Junttila et al. · Annals of Oncology · 2005 · 656 citations

Intestinal Type, Oncology, Gastrointestinal Oncology +11

Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy.

Tuula Kuukasjärvi, Juha Kononen, Heikki Helin et al. · Journal of Clinical Oncology · 1996 · 355 citations

Association of C‐<i>erb</i>B‐2 protein over‐expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long‐term survival in breast cancer

Olli Kallioniemi, Kaija Holli, Tapio Visakorpi et al. · International Journal of Cancer · 1991 · 347 citations

Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up.

Sakari Toikkanen, Heikki Helin, Jorma Isola et al. · Journal of Clinical Oncology · 1992 · 316 citations

Expression of peripheral-type benzodiazepine receptor and diazepam binding inhibitor in human astrocytomas: relationship to cell proliferation.

Helena E. Miettinen, Juha Kononen, Hannu Haapasalo et al. · PubMed · 1995 · 175 citations

Tumor Innervation, Pathology, Cellular Pharmacology +21